Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Upadacitinib may effectively treat alopecia areata without side effects.

Stress-related hair loss was reversed with a special medication.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

New research is helping develop better treatments for alopecia areata.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Heat treatment increases hair loss in certain mice.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Women with alopecia often experience high levels of anxiety and depression, needing psychiatric help.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

JAK inhibitors offer new hope for treating severe alopecia areata.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.